Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera
- PMID: 28356415
- PMCID: PMC5442538
- DOI: 10.1128/JCM.00009-17
Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera
Abstract
Identification of species within the Mycobacterium avium complex (MAC) is difficult, and most current diagnostic laboratory tests cannot distinguish between species included in the complex. Differentiation of species within the MAC is important, as Mycobacterium chimaera has recently emerged as a major cause of invasive cardiovascular infections following open heart surgery. A new commercial diagnostic assay, GenoType NTM-DR ver. 1.0, is intended to differentiate between three species within the MAC, namely, Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium chimaera In this study, we investigated an archival collection of 173 MAC isolates using 16S rRNA and 16S-23S internal transcribed spacer (ITS) gene sequencing, and GenoType NTM-DR was evaluated for identifying M. chimaera and other species belonging to the MAC. Species identification of 157/173 (91%) isolates with the GenoType NTM-DR assay was in agreement with 16S rRNA and 16S-23S ITS gene sequencing results. Misidentification occurred with 16 isolates which belonged to four species included in the MAC that are rarely encountered in clinical specimens. Despite some limitations of this assay, GenoType NTM-DR had 100% specificity for identifying M. chimaera This novel assay will enable diagnostic laboratories to differentiate species belonging to the Mycobacterium avium complex and to accurately identify M. chimaera It can produce rapid results and is also more cost efficient than gene sequencing methods.
Keywords: GenoType NTM-DR; Mycobacterium avium complex; Mycobacterium chimaera; genotypic identification.
Copyright © 2017 American Society for Microbiology.
Figures


Similar articles
-
Comparison of methods available for identification of Mycobacterium chimaera.Clin Microbiol Infect. 2018 Apr;24(4):409-413. doi: 10.1016/j.cmi.2017.07.031. Epub 2017 Aug 4. Clin Microbiol Infect. 2018. PMID: 28782649
-
Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease.J Clin Microbiol. 2013 Jun;51(6):1747-52. doi: 10.1128/JCM.00186-13. Epub 2013 Mar 27. J Clin Microbiol. 2013. PMID: 23536397 Free PMC article.
-
Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.J Antimicrob Chemother. 2017 Jun 1;72(6):1669-1677. doi: 10.1093/jac/dkx021. J Antimicrob Chemother. 2017. PMID: 28333340
-
[Epidemiology, Clinical Presentation, Diagnosis and Treatment of Infections Caused by Mycobacterium chimaera].Pneumologie. 2019 Aug;73(8):474-481. doi: 10.1055/a-0872-8809. Epub 2019 May 10. Pneumologie. 2019. PMID: 31075795 Review. German.
-
Mycobacterium chimaera infections: An update.J Infect Chemother. 2020 Mar;26(3):199-205. doi: 10.1016/j.jiac.2019.11.004. Epub 2019 Dec 13. J Infect Chemother. 2020. PMID: 31843377 Review.
Cited by
-
Diversity and antimicrobial resistance profiles of Mycobacterium avium complex clinical isolates in Thailand based on whole genome comparative analysis.Sci Rep. 2025 Jan 4;15(1):772. doi: 10.1038/s41598-024-84511-z. Sci Rep. 2025. PMID: 39755794 Free PMC article.
-
MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance.Microbiol Spectr. 2024 Oct 3;12(10):e0163824. doi: 10.1128/spectrum.01638-24. Epub 2024 Aug 27. Microbiol Spectr. 2024. PMID: 39189753 Free PMC article.
-
GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.J Clin Microbiol. 2019 Jul 26;57(8):e00516-19. doi: 10.1128/JCM.00516-19. Print 2019 Aug. J Clin Microbiol. 2019. PMID: 31167842 Free PMC article.
-
Characterisation and antimicrobial susceptibility pattern of non-tuberculous mycobacteria.S Afr J Infect Dis. 2024 Jan 5;39(1):525. doi: 10.4102/sajid.v39i1.525. eCollection 2024. S Afr J Infect Dis. 2024. PMID: 38322299 Free PMC article.
-
Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.J Clin Microbiol. 2018 Jan 24;56(2):e01480-17. doi: 10.1128/JCM.01480-17. Print 2018 Feb. J Clin Microbiol. 2018. PMID: 29167290 Free PMC article.
References
-
- Tortoli E, Rindi L, Garcia MJ, Chiaradonna P, Dei R, Garzelli C, Kroppenstedt RM, Lari N, Mattei R, Mariottini A, Mazzarelli G, Murcia MI, Nanetti A, Piccoli P, Scarparo C. 2004. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 54:1277–1285. doi:10.1099/ijs.0.02777-0. - DOI - PubMed
-
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society Infectious Disease Society of America. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416. doi:10.1164/rccm.200604-571ST. - DOI - PubMed
-
- Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, Lipman M, Abubakar I. 2016. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012. BMC Infect Dis 16:195. doi:10.1186/s12879-016-1521-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases